Actavis antibiotic combo Avycaz OK'd for 2 infections

Actavis won the FDA's approval on 25 February to market Avycaz, an antibiotic combination containing ceftazidime and avibactam, to treat complicated intra-abdominal infections (cIAI) and complicated urinary tract infections (cUTI).

More from Anti-infective

More from Therapy Areas